Thorsten Rieckmann

1.7k citations

50 papers · 1.3k indexed · h-index 20

Impact in

Otorhinolaryngology top 1%
- Head and Neck Cancer Studies
Oncology top 5%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers

Papers in

Otorhinolaryngology 13
- Head and Neck Cancer Studies 13
Oncology 30
- Cancer-related Molecular Pathways 10
- PARP inhibition in cancer therapy 7
- Peptidase Inhibition and Analysis 4

Co-authors: Malte Kriegs Ekkehard Dikomey Chia‐Jung Busch Cordula Petersen Silke Tribius Tobias Grob Beat Trüeb Kai Rothkamm
Journals: Radiotherapy and Oncology (8 papers)Oncotarget (5 papers)Cancers (3 papers)Frontiers in Oncology (3 papers)Strahlentherapie und Onkologie (3 papers)
Partner nations: Germany Switzerland United States

In The Last Decade

Thorsten Rieckmann

48 papers receiving 1.3k citations

Peers

Countries citing papers authored by Thorsten Rieckmann

Since Specialization

Citations

This map shows the geographic impact of Thorsten Rieckmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thorsten Rieckmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thorsten Rieckmann more than expected).

Fields of papers citing papers by Thorsten Rieckmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thorsten Rieckmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thorsten Rieckmann. The network helps show where Thorsten Rieckmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Thorsten Rieckmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thorsten Rieckmann Line = papers co-authored together Thorsten Rieckmann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Quantification of human papillomavirus cell-free DNA from low-volume blood plasma samples by digital PCR Microbiology Spectrum ·Yuchao Gu, Matthias Meier, Lea Schroeder, Simon Laban, Thomas K. Hoffmann, Andreas M. Kaufmann, Oliver Siefer, Nora Wuerdemann, Jens Peter Klußmann, Thorsten Rieckmann, 武彦折茂, Daniel L. Faden, Tim Waterboer, Daniela Höfler	2024	5
2	Aqueous extracts from Dioscorea sansibarensis Pax show cytotoxic and radiosensitizing potential in 3D growing HPV-negative and HPV-positive human head and neck squamous cell carcinoma models Biomedicine & Pharmacotherapy ·Carson Odell, Anne Vehlow, Heman kaka khan awlla, Simon Lagies, Bernd Kammerer, Thorsten Rieckmann, Nils Cordes	2024	2
3	Tissue microarray analyses of the essential DNA repair factors ATM, DNA-PKcs and Ku80 in head and neck squamous cell carcinoma Radiation Oncology ·Roa’a J. Zidan, Jesse Eyer, Zhang Junli, Nikolaus Möckelmann, Christina Möller‐Koop, Candy Thompson, Nina Struve, Cordula Petersen, Christian Betz, Kai Rothkamm, Adrian Münscher, Till S. Clauditz, Thorsten Rieckmann	2024	0
4	Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells Neoplasia ·Jia Chen, 藤井進也, Atticus Jaramillo, Katherine Tapia C., 松次郎芝野, Thorsten Rieckmann, Markus Hecht, Antoniu‐Oreste Gostian, Benjamin Frey, Rainer Fietkau, Udo S. Gaipl, Michael Rückert	2023	2
5	Impaired DNA double-strand break repair and effective radiosensitization of HPV-negative HNSCC cell lines through combined inhibition of PARP and Wee1 Clinical and Translational Radiation Oncology ·Zhang Junli, I. Ahmed, Margarita Reyes-Amador, Fernanda Ayane de Oliveira Santos, O. Zhukovam., Arne Böttcher, Katharina Stölzel, Anna Sophie Hoffmann, Nina Struve, Malte Kriegs, Cordula Petersen, Christian Betz, Kai Rothkamm, Roa’a J. Zidan, Thorsten Rieckmann	2023	6
6	G2 checkpoint targeting via Wee1 inhibition radiosensitizes EGFRvIII-positive glioblastoma cells Radiation Oncology ·廖全忠, Thorsten Rieckmann, Laura Fernández de Uña, Lhalogyia, I. Ahmed, Margarita Reyes-Amador, Assel Serikkazyyeva, Melanie Schoof, Ulrich Schüller, Cordula Petersen, Martin Mynarek, Kai Rothkamm, Malte Kriegs, Nina Struve	2023	8
7	The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma Journal of Cancer Research and Clinical Oncology ·SALOMÃO E.R., Zhang Junli, Fayez Saad Alghamdi, Nikolaus Möckelmann, C. Droste, Júnior Rhis Lima, Christina Möller‐Koop, Candy Thompson, Kerstin Borgmann, Kai Rothkamm, Christian Betz, Adrian Münscher, Till S. Clauditz, Thorsten Rieckmann	2022	9
8	Src family kinase targeting in head and neck tumor cells using SU6656, PP2 and dasatinib Head & Neck ·Bingfeng Zhai, Alex Alladio, Laura Fernández de Uña, Cordula Petersen, Christian Betz, Kai Rothkamm, Thorsten Rieckmann, O. Zhukovam., Malte Kriegs	2022	0
9	Tissue Microarray Analyses Suggest Axl as a Predictive Biomarker in HPV-Negative Head and Neck Cancer Cancers ·Chia‐Jung Busch, Christian Hagel, Eric R. Little, Zhang Junli, Nikolaus Möckelmann, C. Droste, Christina Möller‐Koop, Candy Thompson, Denise F. Vlachou, Sonja Loges, Kai Rothkamm, Christian Betz, Adrian Münscher, Till S. Clauditz, Thorsten Rieckmann	2022	7
10	Radiosensitisation and enhanced tumour growth delay of colorectal cancer cells by sustained treatment with trifluridine/tipiracil and X-rays Cancer Letters ·Kai Rothkamm, I. Ahmed, Thorsten Rieckmann, Michael Horn, Thorsten Frenzel, 暁菅野, Udo Schumacher, Alexander Stein, Cordula Petersen, Susanne Burdak‐Rothkamm	2020	10
11	Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer Cancers ·Marcus Wurlitzer, Nikolaus Möckelmann, Malte Kriegs, Maren Vens, H Maleki Ebrahim, Laura Fernández de Uña, Jesse Eyer, Christina Möller‐Koop, Candy Thompson, C. Droste, Zhang Junli, 文寿佐橋, Chia‐Jung Busch, Adrian Münscher, Hartmut Schlüter, Till S. Clauditz, Thorsten Rieckmann	2020	11
12	Current studies of immunotherapy in head and neck cancer Clinical Otolaryngology ·محمدمهدی سالاری, Thorsten Rieckmann, Adrian Münscher, Chia‐Jung Busch	2017	55
13	Targeted nanoparticles for tumour radiotherapy enhancement—the long dawn of a golden era? Annals of Translational Medicine ·E. Gargioni, Florian Schulz, Annette Raabe, Susanne Burdak‐Rothkamm, Thorsten Rieckmann, Kai Rothkamm	2016	11
14	Situation of young radiation oncologists, medical physicists and radiation biologists in German-speaking countries Strahlentherapie und Onkologie ·David Krug, René Baumann, Thorsten Rieckmann, Emmanouil Fokas, Tobias Gauer, Maximilian Niyazi	2016	10
15	Perspectives in chemosensitivity and chemoresistance assays and their implementation in head and neck cancer European Archives of Oto-Rhino-Laryngology ·O. Zhukovam., Chia‐Jung Busch, Balázs B. Lőrincz, Thorsten Rieckmann, Andreas Block, Rainald Knecht	2016	9
16	HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity Radiotherapy and Oncology ·Thorsten Rieckmann, Silke Tribius, Tobias Grob, Felix Meyer, Chia‐Jung Busch, Cordula Petersen, Ekkehard Dikomey, Malte Kriegs	2013	250
17	p53 modulates homologous recombination at I-SceI-induced double-strand breaks through cell-cycle regulation Oncogene ·Thorsten Rieckmann, Malte Kriegs, Lucio Nitsch, Laura Fernández de Uña, Gabor Rohaly, E. I. P�rez, Cordula Petersen, Ekkehard Dikomey, Irena Dornreiter, Jochen Dahm‐Daphi	2012	20
18	Characterization of the first FGFRL1 mutation identified in a craniosynostosis patient Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Thorsten Rieckmann, Lei Zhuang, Christa E. Flück, Beat Trüeb	2008	37
19	The cell surface receptor FGFRL1 forms constitutive dimers that promote cell adhesion Experimental Cell Research ·Thorsten Rieckmann, Salas Supalakwatchana, Beat Trüeb	2007	39
20	Fish possess multiple copies of fgfrl1, the gene for a novel FGF receptor Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Beat Trüeb, Stephan C. F. Neuhauss, J. A. Tenorio, Thorsten Rieckmann, Christof Schild, Héctor Aguilar Miller	2004	26

About Thorsten Rieckmann

Thorsten Rieckmann is a scholar working on Otorhinolaryngology, Oncology, Applied Microbiology and Biotechnology, Molecular Biology and Genetics, having authored 50 papers that have together received 1.3k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (15 papers), Head and Neck Cancer Studies (13 papers), Cancer-related Molecular Pathways (10 papers), PARP inhibition in cancer therapy (7 papers), Lung Cancer Treatments and Mutations (7 papers), Cervical Cancer and HPV Research (6 papers), Fibroblast Growth Factor Research (4 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Otorhinolaryngology (297 citations), Oncology (607 citations), Cancer Research (220 citations), Molecular Biology (752 citations) and Pulmonary and Respiratory Medicine (259 citations). Thorsten Rieckmann has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Malte Kriegs, Ekkehard Dikomey, Chia‐Jung Busch, Cordula Petersen, Silke Tribius, Tobias Grob, Beat Trüeb, Kai Rothkamm, Felix Meyer and Jochen Dahm‐Daphi. Their work appears in journals such as Radiotherapy and Oncology, Oncotarget, Cancers, Frontiers in Oncology and Strahlentherapie und Onkologie.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact